Association Between MMP2 Gene Polymorphisms and Dilated Cardiomyopathy in a Chinese Han Population
Open Access
- 3 March 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 10 (3) , 1793-1802
Abstract
Aims: Dilated cardiomyopathy (DCM) belongs to the common types of cardiomyopathies. The pathogenesis remains unclear despite the fact that various genes have been found associated with DCM. MMP2 is a zinc-dependent and calcium-containing secreted endoproteinases, which could cleave a broad spectrum of substrates including extracellular matrix components and cytokines. It has proved to play an important role in the cardiovascular diseases. This study aimed to investigate the potential role of MMP2 gene polymorphisms in DCM susceptibility and prognosis in a Chinese Han population. Methods and results: A total of 600 idiopathic DCM patients and 700 healthy controls were enrolled. Patients with contact information were followed up for a median period of 28 months. Three tagged single nucleotide polymorphisms (rs243865, rs2285052, and rs2285053) in the promoter of MMP2 gene were genotyped. A series of function analysis were conducted to illuminate the underlying mechanism. The frequency of rs243865-C allele was increased in DCM patients when compared with healthy controls (P = 0.001). Genotypic frequencies of rs243865 were associated with the susceptibility of DCM in the codominant, dominant, and overdominant models (P < 0.05). Besides, rs243865-C allele presented a correlation with the poor prognosis of DCM patients in both dominant (HR = 2.0, 95% confidence interval [CI] = 1.14–3.57, P = 0.017) and additive (HR = 1.85, 95% CI = 1.09–3.13, P = 0.02) model. The statistical significance remained after adjustment for sex, age, hypertension, diabetes, hyperlipidaemia, and smoking status. There were significant differences in left ventricular end-diastolic diameter and left ventricular ejection fraction between rs243865-CC and CT genotypes. Functional analysis indicated that rs243865-C allele increased luciferase activity and the mRNA expression level of MMP2 by facilitating ZNF354C binding. Conclusions: Our study suggested that MMP2 gene polymorphisms were associated with DCM susceptibility and prognosis in the Chinese Han population.Keywords
Funding Information
- Panzhihua Science and Technology Bureau (2020ZD-S-26)
- Sichuan Medical Association Program (2019TG17)
- Sichuan Medical Association Program (S20020)
- Xinglin Scholar Program of Chengdu University of Traditional Chinese Medicine in 2020 (yyzx2020127)
This publication has 34 references indexed in Scilit:
- Immediate administration of atorvastatin decreased the serum MMP-2 level and improved the prognosis for acute heart failureJournal of Cardiology, 2012
- A Novel Loss-of-Function DDAH1 Promoter Polymorphism Is Associated With Increased Susceptibility to Thrombosis Stroke and Coronary Heart DiseaseCirculation Research, 2010
- Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndromeClinical Science, 2009
- The Classification Concept of the ESC Working Group on Myocardial and Pericardial Diseases for Dilated CardiomyopathyHerz, 2007
- Effect of MMP-2 Deficiency on Atherosclerotic Lesion Formation in ApoE-Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Targeted Deletion of Matrix Metalloproteinase 2 Ameliorates Myocardial Remodeling in Mice With Chronic Pressure OverloadHypertension, 2006
- Hyperlipidemia Attenuates the Infarct Size-Limiting Effect of Ischemic Preconditioning: Role of Matrix Metalloproteinase-2 InhibitionThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathiesVirchows Archiv, 2005
- The Epidemiology of Childhood Cardiomyopathy in AustraliaNew England Journal of Medicine, 2003
- Thyroxine Therapy in Patients with Severe Nonthyroidal Illnesses and Low Serum Thyroxine Concentration*The Journal of Clinical Endocrinology & Metabolism, 1986